HLB Pharmaceutical Co. Ltd Net Asset Quality Index
HLB Pharmaceutical Co. Ltd net asset quality index. HLB Pharmaceutical Co. Ltd (047920) has a Net Asset Quality Index of 72.0% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩167.93 Billion minus total liabilities of ₩46.98 Billion yields net assets of ₩120.95 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check HLB Pharmaceutical Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of HLB Pharmaceutical Co. Ltd (2014–2024)
Net asset quality index of HLB Pharmaceutical Co. Ltd from 2014 to 2024. This chart shows how HLB Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 72.0%, representing net assets of ₩120.95 Billion against total assets of ₩167.93 Billion KRW. See HLB Pharmaceutical Co. Ltd (047920) shareholders funds for net asset value and shareholders' equity analysis.
HLB Pharmaceutical Co. Ltd Net Asset Quality Index by Year (2014–2024)
HLB Pharmaceutical Co. Ltd net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for HLB Pharmaceutical Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see HLB Pharmaceutical Co. Ltd market cap and net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.7% | ₩116.40 Billion | ₩157.93 Billion | ₩41.53 Billion | ▲ +11.3 pp |
| 2023 | 62.4% | ₩88.15 Billion | ₩141.35 Billion | ₩53.20 Billion | ▲ +1.9 pp |
| 2022 | 60.4% | ₩85.93 Billion | ₩142.18 Billion | ₩56.25 Billion | ▼ -1.0 pp |
| 2021 | 61.4% | ₩78.38 Billion | ₩127.63 Billion | ₩49.25 Billion | ▲ +21.4 pp |
| 2020 | 40.0% | ₩44.62 Billion | ₩111.42 Billion | ₩66.80 Billion | ▲ +2.6 pp |
| 2019 | 37.4% | ₩17.36 Billion | ₩46.39 Billion | ₩29.04 Billion | ▼ -9.3 pp |
| 2018 | 46.7% | ₩17.00 Billion | ₩36.42 Billion | ₩19.42 Billion | ▲ +4.5 pp |
| 2017 | 42.2% | ₩16.80 Billion | ₩39.85 Billion | ₩23.04 Billion | ▼ -3.7 pp |
| 2016 | 45.8% | ₩18.90 Billion | ₩41.24 Billion | ₩22.34 Billion | ▼ -3.2 pp |
| 2015 | 49.0% | ₩12.18 Billion | ₩24.85 Billion | ₩12.67 Billion | ▲ +26.5 pp |
| 2014 | 22.5% | ₩4.81 Billion | ₩21.43 Billion | ₩16.62 Billion | — |